Chemical Compound
2-Pyridinesulfonamide, N-[3-[(1R)-1-[(6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-; 2-Pyridinesulfonamide, N-[3-[1-[5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-, [R-(R*,R*)]-; N-[3-[(1R)-1-[(6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide; Aptivus; PNU 140690; TPV; Tipranavir; U 140690
CAS Registry Number
174484-41-4
Primary record
2-Pyridinesulfonamide, N-[3-[(1R)-1-[(6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-; 2-Pyridinesulfonamide, N-[3-[1-[5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-, [R-(R*,R*)]-; N-[3-[(1R)-1-[(6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide; Aptivus; PNU 140690; TPV; Tipranavir; U 140690
- 库存
- 5,427 克
- 纯度
- 99.8 %
- CAS
- 174484-41-4
化合物标识与属性
- CAS
- 174484-41-4
- PubChem CID
- 54682461
- SMILES
- CCC[C@]1(CC(=C(C(=O)O1)[C@H](CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4
- Canonical SMILES
- CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1
名称与同义词
- Tipranavir
- Aptivus
- 174484-41-4
- tipranavirum
- Tipranavir?
- Aptivus(TM)
- Tipranavir (INN)
- Aptivus (TN)
- PNU-140690
- Tipranavir [INN:BAN]
- Tipranavir (Standard)
- Tipranavir Impurity 1
- 1d4y
- 2o4l
- 2o4n
- 2o4p
- RefChem:58436
- TIPRANAVIR [MI]
- CHEBI:63628
- AC1Q4JPW
- TIPRANAVIR [INN]
- UNII-ZZT404XD09
- ZZT404XD09
- D-(+)-Phenyllactic acid
- C31H33F3N2O5S
- DTXSID6048622
- TIPRANAVIR [VANDF]
- D0EV6T
- Epitope ID:231717
- AC1L22FH
- TIPRANAVIR [MART.]
- Aptivus (Boehringer Ingelheim)
- TIPRANAVIR [WHO-DD]
- SCHEMBL40629
- SCHEMBL40630
- DTXCID9028548
- HSDB 8083
- PNU 140690
- TIPRANAVIR [EMA EPAR]
- CHEMBL183041
- CHEMBL222559
- orb1745235
- Tipranavir - Bio-X trade mark
- SCHEMBL29393318
- SCHEMBL29714122
- TIPRANAVIR [ORANGE BOOK]
- CTK8E7540
- GTPL12685
- PNU-140690E
- tipranavir, (R-(R*,R*))-
- J05AE09
- U-140690
- NZPXPXAGXYTROM-FYBSXPHGSA-N
- SUJUHGSWHZTSEU-FYBSXPHGSA-N
- tipranavir(pnu-140690,aptivus)
- CID65027
- EX-A4113
- Tox21_112962
- BDBM50479982
- EBC-27374
- HY-15148R
- MFCD00949098
- NSC831852
- AKOS030254403
- ZINC100016058
- ZINC100022637
- AN-5550
- CS-1210
- DB00932
- FT28290
- NSC-831852
- C31-H33-F3-N2-O5-S
- NCGC00182028-01
- NCGC00379087-01
- NCGC00379087-02
- AS-79082
- BT300133
- HY-15148
- TPV
- U 140690
- 2-Pyridinesulfonamide, N-[3-[(1R)-1-[(6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-
- J790.736B
- RT-016034
- A3876
- CAS-174484-41-4
- NS00015496
- X2005
- D08605
- F84910
- W-5247
- A811642
- EN300-19769351
- Q423404
- 3'-((1R)-1-((6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-phenethyl-6-propyl-2H-pyran-3-yl)propyl)-5-(trifluoromethyl)-2-pyridinesulfonanilide
- N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide
- N-(3-{(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide
- N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE
- N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide
- N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulfonamide
- 2-Pyridinesulfonamide, N-(3-((1R)-1-((6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-
- 2-Pyridinesulfonamide, N-(3-(1-(5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-, (R-(R*,R*))-
- N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide
- N-[3-[(1R)-1-[(6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide
- 191150-83-1
- 2-Pyridinesulfonamide, N-[3-[(1R)-1-[(6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-; 2-Pyridinesulfonamide, N-[3-[1-[5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-, [R-(R*,R*)]-; N-[3-[(1R)-1-[(6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide; Aptivus; PNU 140690; TPV; Tipranavir; U 140690
- 629-839-6
- N-(3-((1R)-1-((2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl)propyl)phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide
- N-(3-((R)-1-((R)-4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide
- N-(3-((R)-1-((R)-6-hydroxy-4-oxo-2-phenethyl-2-propyl-3,4-dihydro-2H-pyran-5-yl)propyl)phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide
- N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide
- N-[3-[(1R)-1-[(6R)-2-Hydroxy-4-oxo-6-phenethyl-6-propyl-5H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide
- N-[3-[(1R)-1-[(6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propy l-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide
- N-[3-[(R)-1-(2-Oxo-4-hydroxy-6beta-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide
- N-[3-[(R)-1-[[(R)-2-Oxo-4-hydroxy-6beta-phenethyl-6-propyl-5,6-dihydro-2H-pyran]-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide
- N-[3-[(R)-1-[[(R)-5,6-Dihydro-4-hydroxy-6-propyl-6-(2-phenylethyl)-2-oxo-2H-pyran]-3-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide